Pall to Open Latest Life Sciences Centre of Excellence in Portsmouth (UK)
News Apr 08, 2013
This latest COE will complement recently announced Life Sciences Centres in the United States (Westborough, Massachusetts and Menlo Park, California) as well as investments previously announced in China, Singapore and India.
“The announcement of Pall’s new Portsmouth Centre of Excellence provides another example of our commitment to meeting the diverse needs of our Life Sciences customers across the globe,” said Yves Baratelli, president, Pall Life Sciences. "Portsmouth represents an important Life Sciences hub for Pall. By upgrading and expanding our capabilities at the site, we are not only enhancing our ability to service our customers, but also creating a multi-disciplinary and responsive environment in which Pall scientists and engineers can thrive and innovate.”
The new Portsmouth COE will include a dedicated 4000 m² scientific area with a connected walkway to another recently opened facility that houses an additional 2000 m² for Life Sciences technical support and training, R&D engineering and product management. Manufacturing and test areas will remain at the current Walton Road site in Portsmouth.
In addition to customer service support, COE offerings will include the development, testing and validation of a wide range of products that now form part of Pall's portfolio. There also will be an extensive range of scale-up technology on hand for applying industry-leading standards to match demands for fully representative and rapid drug development.
Single-Dose Vaccine Could Provide Faster Protection in Cholera EpidemicsNews
Each year there are more than three million cases of cholera worldwide, a disease transmitted through contaminated food and water that hits developing countries particularly hard. While the standard regimen for protecting against cholera with existing non-living oral cholera vaccines includes administering two doses over a two-week period, research now shows that giving a stronger single-dose of a live oral vaccine could be an effective tool in controlling outbreaks more quickly.READ MORE
Agent Reverses Resistance to Targeted Drug in Some LeukemiasNews
After discovering how some hematologic cancer cells manage to elude death from a targeted therapy, Dana-Farber Cancer Institute scientists have double-crossed the cancer cells with a drug that renders them vulnerable to the targeted agent.READ MORE